![ICON PLC Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/iclr.png?tr=w-200)
ICON PLC
NASDAQ:ICLR
![ICON PLC Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/iclr.png)
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Realty Income Corp
NYSE:O
|
Real Estate
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
Media
|
US |
![]() |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
222.83
346.2
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Realty Income Corp
NYSE:O
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
US |
![]() |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/iclr.png)
Intrinsic Value
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. [ Read More ]
The intrinsic value of one
ICLR
stock under the Base Case scenario is
330.555
USD.
Compared to the current market price of 321.915 USD,
ICON PLC
is
Undervalued by 3%.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/iclr.png?tr=w-200)
Valuation Backtest
ICON PLC
Run backtest to discover the historical profit from buying and selling
ICLR
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
ICON PLC
Current Assets | 3.6B |
Cash & Short-Term Investments | 398m |
Receivables | 3B |
Other Current Assets | 149.1m |
Non-Current Assets | 13.5B |
Long-Term Investments | 51.2m |
PP&E | 512.9m |
Intangibles | 12.8B |
Other Non-Current Assets | 162m |
Current Liabilities | 2.9B |
Accounts Payable | 113.6m |
Other Current Liabilities | 2.8B |
Non-Current Liabilities | 4.7B |
Long-Term Debt | 3.4B |
Other Non-Current Liabilities | 1.2B |
Earnings Waterfall
ICON PLC
Revenue
|
8.2B
USD
|
Cost of Revenue
|
-5.8B
USD
|
Gross Profit
|
2.4B
USD
|
Operating Expenses
|
-1.3B
USD
|
Operating Income
|
1.1B
USD
|
Other Expenses
|
-417.2m
USD
|
Net Income
|
683.2m
USD
|
Free Cash Flow Analysis
ICON PLC
USD | |
Free Cash Flow | USD |
ICLR Profitability Score
Profitability Due Diligence
ICON PLC's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/iclr.png)
Score
ICON PLC's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
ICLR Solvency Score
Solvency Due Diligence
ICON PLC's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/iclr.png)
Score
ICON PLC's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ICLR Price Targets Summary
ICON PLC
According to Wall Street analysts, the average 1-year price target for
ICLR
is 373.32 USD
with a low forecast of 333.3 USD and a high forecast of 409.5 USD.
Price Appreciation
ICLR Price
ICON PLC
Average Annual Return | 10.02% |
Standard Deviation of Annual Returns | 36.33% |
Max Drawdown | -35% |
Market Capitalization | 26.6B USD |
Shares Outstanding | 82 777 296 |
Percentage of Shares Shorted | 2.44% |
Company Profile
![ICON PLC Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/iclr.png?tr=w-200)
![ICON PLC Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/iclr.png?tr=w-200)
Country
Industry
Market Cap
Dividend Yield
Description
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. The company is headquartered in Dublin, Dublin and currently employs 38,330 full-time employees. The firm is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. The firm specialises in the strategic development, management and analysis of programs that support clinical development from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The company conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The firm offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.
Contact
IPO
Employees
Officers
The intrinsic value of one
ICLR
stock under the Base Case scenario is
330.555
USD.
Compared to the current market price of 321.915 USD,
ICON PLC
is
Undervalued by 3%.